Millennium Management LLC Acquires New Shares in Cardlytics, Inc. (NASDAQ:CDLX)

Millennium Management LLC acquired a new stake in shares of Cardlytics, Inc. (NASDAQ:CDLX) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 144,238 shares of the company’s stock, valued at approximately $535,000. Millennium Management LLC owned about 0.28% of Cardlytics at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Mirabella Financial Services LLP purchased a new stake in shares of Cardlytics during the fourth quarter valued at $4,285,000. D. E. Shaw & Co. Inc. lifted its holdings in Cardlytics by 97.4% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,131,505 shares of the company’s stock valued at $4,198,000 after acquiring an additional 558,235 shares during the period. Geode Capital Management LLC lifted its holdings in Cardlytics by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 1,060,739 shares of the company’s stock valued at $3,936,000 after acquiring an additional 7,561 shares during the period. RBF Capital LLC lifted its holdings in Cardlytics by 64.7% in the fourth quarter. RBF Capital LLC now owns 803,763 shares of the company’s stock valued at $2,982,000 after acquiring an additional 315,635 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Cardlytics by 3.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 402,552 shares of the company’s stock valued at $1,493,000 after acquiring an additional 12,209 shares during the period. 68.10% of the stock is owned by hedge funds and other institutional investors.

Cardlytics Stock Up 6.5%

NASDAQ CDLX opened at $1.79 on Monday. The stock’s 50-day moving average price is $1.71 and its 200-day moving average price is $2.66. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics, Inc. has a 52 week low of $1.22 and a 52 week high of $9.78. The company has a market capitalization of $93.98 million, a P/E ratio of -0.29 and a beta of 1.25.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CDLX. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Thursday, March 13th. Evercore ISI lowered their target price on Cardlytics from $4.00 to $3.00 and set an “in-line” rating on the stock in a report on Thursday, March 13th. Finally, Lake Street Capital lowered their target price on Cardlytics from $3.00 to $2.50 and set a “hold” rating on the stock in a report on Thursday, May 8th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Cardlytics has a consensus rating of “Hold” and an average target price of $5.20.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.